This site is intended for healthcare professionals only
Search
Close this search box.

Research focus: ‘Health not height’ – Trial results for a targeted treatment for children with achondroplasia

Professor Ravi Savarirayan talks through the recently published results in The New England Journal of Medicine for the C-type natriuretic peptide analogue vosoritide in children with achondroplasia.

Martin Savage
Programme Director
Sign up for eAlerts
Be the first to hear about new resources and content by signing up to receive our eAlerts.
Sign up
Follow us
Twitter
Contact us
Privacy policy
Terms of use
Legal disclaimer
This programme is made possible thanks to an educational grant received from Merck Healthcare KGaA, Darmstadt, Germany.
medwireNews is an independent clinical news service provided by Springer Healthcare Limited. © 2024 Springer Healthcare is part of the Springer Nature Group
We'd love your feedback!

We'd love your feedback!

Please complete this short 5-question survey to help improve the content offered on this website.
Please rank the following aspects of the program from best [1] to worst [4].
No thanks, not at this time